Monotherapy with Metformin versus Sulfonylureas and Risk of Cancer in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis.

Mekuria, Abraham Nigussie; Ayele, Yohanes; Tola, Assefa; Mishore, Kirubel Minsamo

Mekuria, Abraham Nigussie; Ayele, Yohanes; Tola, Assefa; Mishore, Kirubel Minsamo.

Afiliação

Mekuria AN; Department of Pharmacology, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Ayele Y; Department of Clinical Pharmacy, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Tola A; Department of Epidemiology and Biostatistics, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Mishore KM; Department of Clinical Pharmacy, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.

J Diabetes Res ; 2019: 7676909, 2019.

Article em En | MEDLINE | ID: mdl-31828167

Assuntos

Diabetes Mellitus Tipo 2/tratamento farmacológico; Hipoglicemiantes/uso terapêutico; Metformina/uso terapêutico; Neoplasias/epidemiologia; Compostos de Sulfonilureia/uso terapêutico; Humanos; Incidência

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Epidemiologia / Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Compostos de Sulfonilureia / Diabetes Mellitus Tipo 2 / Hipoglicemiantes / Metformina / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: J Diabetes Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Etiópia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google